Drug developer seeks $100M for new cancer treatment
Incyclix Bio seeks $100 million to support cancer studies. The company is developing a CDK2 inhibitor called INX-315.
News Medical on MSN8d
Chemical compound lights up treatment-resistant cancers on imaging scans
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.